Karyopharm TherapeuticsSelinexor (ATG-010) (rolling submission) : 2018-07-18 : , - 2018718,Karyopharm Therapeutics Inc. (Nasdaq:KPTI) (selective inhibitor of nuclear export, SINE) selinexor (ATG-010) (multiple myeloma, MM) (New Drug Application, NDA) (rolling submission), (proteasome inhibitors, PIs) (Velcade(R), bortezomib) (Kyprolis(R), carfilzomib) (immunomodulatory drugs, IMiDs) (Revlimid(R), lenalidomide) (Pomalyst(R), pomalidomide)anti-CD38Darzalex(R) (daratumumab), Karyopharm ,Karyopharm Therapeutics2019 (European Medicines Agency, EMA) (Marketing Authorization Application, MAA) 529,()KaryopharmMichael G.